Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Lignocaine vs Dexmedetomidine for Pressor Response in Hypertensive Patients
NCT07897578Completed
- Sponsor
- Tanta University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised trial in pressor response comparing Group D (Dexmedetomidine) with Group L (Lignocaine) (2 arms). Primary endpoint: Assessment of blunting Pressor Response to Laryngoscopy. Started Dec 2025; status: completed.
02
Drugs
lidocainedexmedetomidine
03
Conditions
pressor response
Beyond the preview
Go deeper on NCT07897578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897578.